Truvestments Capital’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,511
Closed -$38.1K 1146
2024
Q4
$38.1K Hold
5,511
0.01% 413
2024
Q3
$32K Buy
+5,511
New +$33.5K 0.01% 427
2024
Q2
Sell
-11,820
Closed -$44.9K 623
2024
Q1
$44.9K Sell
11,820
-33,081
-74% -$120K 0.02% 361
2023
Q4
$106K Buy
44,901
+7,314
+19% +$17.1K 0.05% 254
2023
Q3
$104K Buy
37,587
+1,911
+5% +$5.84K 0.05% 231
2023
Q2
$112K Buy
35,676
+11,446
+47% +$41.3K 0.06% 231
2023
Q1
$126K Buy
24,230
+9,668
+66% +$69.4K 0.07% 225
2022
Q4
$108K Buy
14,562
+14,341
+6,489% +$129K 0.06% 227
2022
Q3
$3K Hold
221
﹤0.01% 526
2022
Q2
$2K Buy
+221
New +$1.85K ﹤0.01% 576

Other funds holding SRTS

Truvestments Capital's SRTS Position: Q1 2025 in Review

Truvestments Capital sold out of Sensus Healthcare (SRTS) in Q1 2025, closing a stake of 5,511 shares — an estimated $38.1K sold.

Truvestments Capital first reported a position in SRTS in Q2 2022 and held it in 10 quarters. The position peaked at $126K in Q1 2023. 53 funds tracked by Wall St. Rank hold SRTS as of Q1 2025.

  • Truvestments Capital reported no remaining Sensus Healthcare position as of Q1 2025 after selling out during the quarter.
  • Truvestments Capital sold 5,511 Sensus Healthcare shares in Q1 2025, an estimated $38.1K.
  • Truvestments Capital first reported a position in Sensus Healthcare in Q2 2022 and held it in 10 quarters.
  • Truvestments Capital's Sensus Healthcare position peaked at $126K in Q1 2023.
  • 53 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2025.

Based on Truvestments Capital's 13F filing for Q1 2025, filed 14 May 2025.